VWF and von Willebrand disease (hereditary or acquired): Recent therapeutic advances in the treatment of VWD have been slow compared with the evolution of haemophilia treatment, and patients with severe disease are still generally reliant upon plasma‐derived VWF containing concentrates or recombinant VWF where available, for treatment or prevention of bleeds [12, 13].